12:00 AM
 | 
Apr 27, 2015
 |  BC Week In Review  |  Company News  |  Deals

GenVec Inc, TheraBiologics deal

GenVec and TheraBiologics partnered to develop cancer therapeutics using GenVec’s gene delivery technology and TheraBiologics’ neural stem cell (NSC) technology. GenVec will contribute vector...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >